Beskidzkie Centrum Onkologii

What Beskidzkie Centrum Onkologii does

Beskidzkie Centrum Onkologii – Szpital Miejski im. Jana Pawła II is a public municipal hospital located in Bielsko-Biała, southern Poland, serving the Beskid region. The facility operates across three sites — ul. Wyzwolenia 18 (inpatient), ul. Wyspiańskiego 21 (outpatient specialty clinics), and ul. Emilii Plater 17 — and combines a multi-specialty general hospital profile with a focused oncology franchise spanning medical oncology, surgical oncology, radiotherapy, chemotherapy, nuclear medicine, and supportive/palliative care. Adjacent service lines include obstetrics and maternity (with 500 births recorded by June 2026), cardiology and cardio-oncology, and gastroenterology, supported by a Breast Cancer Unit and a Colon Cancer Unit.

The hospital's underlying technology base is centered on capital-intensive diagnostic and therapeutic equipment: a linear accelerator for radiotherapy, a D-SPECT gamma camera, a brachytherapy unit, a semiconductor radiojod system (one of only five such installations in Poland), and what is described as the first DECT scanner in the region. It has held academic hospital status since March 2021 through a partnership with WST Katowice, and maintains ISO 9001, CMJ, and DNV GL accreditations alongside a renewed five-year NFZ public-payer authorization running April 2026 through April 2031.

The business model is that of a publicly funded municipal hospital: the dominant revenue stream is reimbursement from the Narodowy Fundusz Zdrowia (NFZ) under contract authorization, supplemented by a smaller, undisclosed private fee-for-service channel. Customers are individual patients of the Beskid region referred through NFZ pathways, with secondary relationships to academic and teaching partners. Leadership is headed by Director Krzysztof Bestwina, with a 2026 refresh appointing Dr. Rafał Wiśniowski as Deputy Director for Medical Affairs, Prof. Krzysztof Nowosielski to lead gynecologic oncology, and Danuta Wawak as Chief Nurse.

Name

Beskidzkie Centrum Onkologii

Legal name

Beskidzkie Centrum Onkologii – Szpital Miejski im. Jana Pawła II w Bielsku-Białej

Website

https://onkologia.bielsko.pl

Company type

Private

Operating status

Operating

Headcount range

11–50 employees

Short description

Public municipal hospital in Bielsko-Biała, Poland, delivering multi-specialty general medicine alongside an oncology franchise (radiotherapy, nuclear medicine, chemo, surgical oncology) to Beskid-region patients under NFZ reimbursement.

Ownership category

akta.pro rank

Product category

Oncology Hospital Services

NAICS

Specialty (except Psychiatric and Substance Abuse) Hospitals (622310), Hospitals (622)

SIC

Services-Hospitals (8060), Services-Specialty Outpatient Facilities, Nec (8093)

akta.pro primary industry

Oncology & Cancer Specialty Hospitals (HLAFAHAC)

akta.pro secondary industries

Hospital-Integrated Cancer Centers (Acute Oncology Programs) (HLAFAAAM), Radiation Oncology (HLAKAFAC), Medical Oncology (HLAKAFAB)

Keywords

• Oncology hospital services
• Radiotherapy treatment
• Cancer diagnostics
• Nuclear medicine
• Palliative care services

Headquarters

HQ city

Bielsko-Biała

HQ country

Poland

HQ region

Europe

Offices3 records

Markets served

GTM type

B2C

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure, Supply Chain

Revenue model

1. National Health Fund (NFZ) Reimbursement: As a public hospital, BCO-SM's primary revenue comes from reimbursed healthcare services provided under contract with Narodowy Fundusz Zdrowia (NFZ), Poland's national health insurer. The hospital holds a 5-year NFZ authorization (April 2026 – April 2031) covering all provided healthcare services. Services are provided at no direct cost to patients covered by the public insurance system.
2. Fee-for-Service (Private Patients): The hospital publishes fee schedules (cennik) for services, indicating the availability of private-pay services for patients not covered by public insurance or requesting services outside NFZ coverage.

Pricing tiers

Go-to-market motion1 record

Distribution channels6 records

Marketing channels6 records

Core offering

BCO-SM is a municipal public hospital providing comprehensive oncology diagnosis and treatment (surgical oncology, radiotherapy, brachytherapy, chemotherapy, nuclear medicine) integrated with general hospital services including obstetrics/gynecology, neonatal care, cardiology/cardio-oncology, palliative care, and diagnostic imaging. Specialized oncology pathways are delivered through dedicated Breast Cancer Unit and Colon Cancer Unit. Services are delivered primarily under contract with Poland's National Health Fund (NFZ) and supplemented by private-pay services per published fee schedules.

Product overview

Beskidzkie Centrum Onkologii – Szpital Miejski im. Jana Pawła II is a multi-specialty hospital providing comprehensive oncology services alongside general and specialized medical care. The facility operates as a platform of specialized departments and units, with oncology (including surgical oncology, radiotherapy, chemotherapy, and nuclear medicine) as the core offering, complemented by diagnostic imaging (CT, MRI, mammography, dual-energy CT), pathomorphology, palliative care, obstetrics/gynecology with oncological gynecology, and cardiology/cardio-oncology services. Key specialized units include the Breast Cancer Unit and Colon Cancer Unit. The hospital also provides patient-facing digital services through eCareMed and Medyczny Portal Informacyjny platforms for online appointment registration.

Differentiator

Problem solved

Functional benefit

Products and services

• Oncology Treatment Services (Oddział Onkologiczny) Comprehensive cancer diagnosis and treatment including chemotherapy, radiotherapy, and surgical oncology services for various cancer types, serving NFZ-insured and private patients.
• Radiotherapy Department (Zakład Radioterapii) Radiation therapy treatments using advanced high-energy linear accelerator technology for precise cancer treatment.
• Brachytherapy Unit (Pracownia Brachyterapii) Internal radiation therapy services, positioned among the best-equipped brachytherapy units in Poland.
• Nuclear Medicine Department (Zakład Medycyny Nuklearnej) Diagnostic and therapeutic nuclear medicine services including SPECT/CT imaging, D-SPECT cardiac imaging, and personalized radioiodine (Radiojod) treatment for thyroid conditions achieving >90% efficacy.
• Breast Cancer Unit Specialized unit for comprehensive breast cancer diagnosis and treatment, integrating mammography, MRI, mammotomic biopsy, and surgical services.
• Colon Cancer Unit Specialized unit for colorectal cancer screening, diagnosis, and treatment.
• Obstetrics and Gynecology with Oncological Gynecology Obstetric services including delivery care, gynecological services, and specialized oncological gynecology treatments including robotic surgery; recorded 500 births in 2026 as of June 2026.
• Diagnostic Imaging (Zakład Diagnostyki Obrazowej) Advanced medical imaging services including CT, MRI, mammography, ultrasound, and dual-energy CT (DECT).
• Medical Physics Department (Zakład Fizyki Medycznej) Medical physics support for radiotherapy planning and quality assurance in radiation treatment.
• Pathomorphology Department (Zakład Patomorfologii) Histopathological and cytological diagnostics for cancer diagnosis.
• Analytical Laboratory (Laboratorium Analityczne) Clinical laboratory testing services including coagulation analyzers (Sysmex CS-1600) for patient diagnostics.
• Palliative Care (Opieka Paliatywna) Inpatient palliative care unit, palliative medicine outpatient clinic, and home palliative care team (Hospicjum Domowe).
• Cardiology and Cardio-Oncology Department Cardiology services including cardiac CT, echocardiography, Holter monitoring, and specialized cardio-oncology care for cancer patients.
• eCareMed Online Appointment Registration Online appointment registration platform for patient convenience in scheduling hospital visits.
• Medyczny Portal Informacyjny (MPI) Medical information portal providing online registration and access to patient services.

Quantifiable outcome

• Over 90% efficacy in radical radiojod (radioiodine) treatment for hyperthyroidism
• +1 more outcomes

Named customers1 record

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

Feature7 records

Partnerships

Two partnerships are on record, tiered core.

• Wyższa Szkoła Techniczna w Katowicach (WST) - Faculty of Medical SciencescoreStrategic or Co-development Partner · 1 March 2021Since March 1, 2021, BCO-SM hosts Katedry i Oddziały Kliniczne (Chairs and Clinical Departments) of the Faculty of Medical Sciences of Wyższa Szkoła Techniczna in Katowice at the Zabrze campus. This academic partnership integrates clinical care with medical education and research, with the first students attending from April 12, 2021. This is a significant organizational achievement confirming the hospital's high quality standards and enabling medical student training within the facility.
• Narodowy Fundusz Zdrowia (NFZ) - National Health FundcoreOthersBCO-SM operates under a 5-year authorization from NFZ (April 2026 – April 2031) to provide healthcare services. NFZ is Poland's national health insurer and the primary payer for the hospital's services. The authorization process included detailed verification of the hospital's operations, staff qualifications, equipment, and compliance with quality and safety standards.

Scale indicators8 records

Recent moves6 records

Expansion highlights5 records

Broad incumbents

• European Institute of Oncology (IEO): Milan-based specialty oncology hospital and research center offering comprehensive cancer care with strong nuclear medicine and radiotherapy capabilities. Comparable in clinical model though materially larger and privately affiliated.
• Karolinska Comprehensive Cancer Center: Academic cancer center within Karolinska University Hospital in Stockholm, combining oncology specialty care with research and education. Comparable in academic hospital status, multi-modality cancer services, and nuclear medicine capabilities.

Direct peers

• Świętokrzyskie Centrum Onkologii: Holy Cross Cancer Center in Kielce, a regional specialty oncology hospital serving a defined Polish catchment area. Comparable in scale, multi-modality offerings, and NFZ-funded public hospital structure.
• Narodowy Instytut Onkologii im. Marii Skłodowskiej-Curie: Poland's largest national oncology reference center in Warsaw, explicitly referenced as a comparable institution for BCO-SM's semiconductor-based radioiodine capability. Operates as the premier specialty oncology hospital in Poland with a similar multi-modality clinical model.
• Wielkopolskie Centrum Onkologii: Greater Poland Cancer Center in Poznań, one of Poland's leading regional oncology specialty hospitals. Comparable as a multi-site public oncology center with similar diagnostic, treatment, and research integration.
• Dolnośląskie Centrum Onkologii, Pulmonologii i Hematologii: Lower Silesian specialty oncology center in Wrocław providing comprehensive cancer care including radiotherapy, chemotherapy, and surgical oncology. Highly comparable in regional specialty hospital positioning and public payer model.
• Centrum Onkologii im. prof. Tadeusza Koszarowskiego: Regional specialty oncology center in Krakow providing surgical oncology, radiotherapy, chemotherapy, and nuclear medicine services. Closely comparable in scope, public-hospital status, and regional referral role to BCO-SM.

Regional players

• Uniwersyteckie Centrum Kliniczne im. prof. K. Gibińskiego: Academic medical center in Katowice (Silesian Voivodeship) hosting oncology services and serving as a clinical partner of the same medical faculty network as BCO-SM. Comparable academic-affiliation model and overlapping patient catchment.
• Szpital Specjalistyczny im. Ludwika Rydygiera w Krakowie: Polish multi-specialty public hospital with significant oncology and surgical programs in Krakow. Comparable in being a regional public hospital with NFZ authorization and a mix of general and oncology services.

Others

• Centrum Diagnostyki i Leczenia Nowotworów Piersi (Breast Cancer Units network): Network of dedicated breast cancer diagnostic and treatment units across Polish hospitals certified under national oncology pathways. Comparable as a structural peer for BCO-SM's Breast Cancer Unit operating model within the public system.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/beskidzkie-centrum-onkologii

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Beskidzkie Centrum Onkologii